EMERGO GROUP INVESTS IN SURREY'S INNOVATION BOULEVARD BY RELOCATING TO SURREY, BC
Ideas get bigger when you share them...
Surrey, BC - March 24, 2014 (www.investorideas.com newswire) Rene van de Zande, the global President and Chief Executive Officer for Emergo Group and Daryl Wisdahl, managing director of the Canadian office have announced that they are expanding their operation and the size of their facilities in Greater Vancouver. Emergo Group, a global medical device-consulting firm has moved its office headquarters from Vancouver to Surrey, BC and expanded its office to accommodate the increasing staff.
"I am very proud of our team. Their expertise in the medical device industry has aided our companies' growth to the point that we are now doubling the size our office in Surrey," said Mr. Wisdahl. "I believe that the significance of this move and the strong expertise of our staff will pave the way for more jobs for the people of Surrey and more opportunities for our company to be a major part of Surrey's Innovation Boulevard."
To celebrate the occasion, Emergo Group hosted an open house in Surrey, BC on 20 March 2014. Rene van de Zande, President and Chief Executive Officer, joined with the staff at the Surrey Office to mark the occasion. "We were very excited that a number of our clients, as well as Ms. Nina Grewal, MP Surrey-Fleetwood, Minister Stephanie Cadieux, MLA Surrey-Cloverdale, the Surrey Board of Trade, the City of Surrey Economic Development, and the Fleetwood Community Association were able to attend our event," said Mr. Wisdahl.
"Our company has a long-term strategic vision to provide medical device companies with opportunities to access markets by providing in–country market access, regulatory and quality management system consulting," said Mr. van de Zande. "Amalgamating offices in Surrey, one of Canada's fastest growing cities and home of Innovation Boulevard, a city-driven program supporting the growth of companies in the health care technology and services sectors, supports our global Mission Statement: "to facilitate quality medical care worldwide by helping medical device manufacturers introduce products to global markets efficiently without compromising on compliance and safety for users and patients."
Established in 1997 to help US medical device companies export to Europe, Emergo Group grew quickly to become a leading strategic medical device-consulting firm. Today they maintain offices in 25 countries and provide a wide range of compliance and market access services. They assist companies with global regulatory strategy, device registration and distributor qualification.
Name: Chris Schorre, VP Marketing, Emergo Group or Daryl Wisdahl, Managing Director, Canada, Emergo Group
Published at the Investorideas.com Newswire - Big ideas for Global Investors
Disclaimer/ Disclosure:The Investorideas.com newswire is a third party publisher of news and research as well as creates original content as a news source. Original content created by investorideas is protected by copyright laws other than syndication rights. Investorideas is a news source on Google news and Linkedintoday plus hundreds of syndication partners. Our site does not make recommendations for purchases or sale of stocks or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated by featured companies, news submissions, content marketing and online advertising. Contact each company directly for press release questions. Disclosure is posted on each release if required but otherwise the news was not compensated for and is published for the sole interest of our readers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.